Overview
- Trump threatened a 100% duty on branded or patented drug imports effective Oct. 1 unless manufacturers build production plants in the United States.
- Pfizer obtained a three-year exemption from those tariffs by agreeing to lower prices on several medicines, including deeper Medicaid discounts and reduced prices offered through a government-run website.
- Pfizer said some discounts will reach up to 85% and average about 50%, and it pledged an additional $70 billion in U.S. infrastructure investment.
- Trump said all new Pfizer medicines introduced in the U.S. will launch at reduced prices aligned with the lowest levels in comparable countries.
- The White House announced a consumer platform called TrumpRx to direct patients to discounted direct sales starting in 2026, while key details such as which drugs are covered and how the tariff policy will be enforced remain unsettled.